Sponsored by TearLab
The most eff ective way to combat CL dropout is to identify patients who are at risk before they start to complain. Once a patient is complaining, it’s often too late. We need to identify which patients are at risk of dropping out prior to first fittings and at each exam thereafter.
The TearLab test makes this easy to accomplish. And, in the event you need to ask a patient to spend more money, you can be sure that the patient can see real value in the objective evidence that you present.
The most eff ective way to combat CL dropout is to identify patients who are at risk before they start to complain. Once a patient is complaining, it’s often too late. We need to identify which patients are at risk of dropping out prior to first fittings and at each exam thereafter.
The TearLab test makes this easy to accomplish. And, in the event you need to ask a patient to spend more money, you can be sure that the patient can see real value in the objective evidence that you present.
Additional Publications
-
Innovations in Glaucoma Care & Treatment
Sponsored by Bausch + Lomb
Proceedings of the 17th Annual Meeting of the Optometric Glaucoma Society Women in Optometry - March 2019
Ophthalmic Product Guide - February 2019
Aligning Practice with Perception—A Global Roundtable. Sponsored by Cooper Vision
2019 Conference Planner
Managing Advanced IOLs in Today’s Cataract Patient. Sponsored by Johnson & Johnson Vision
